Atea Pharmaceuticals Inc (AVIR) — Cash Flow Quality Index
Atea Pharmaceuticals Inc (AVIR) has a Cash Flow Quality Index of -0.64x as of December 2021. Operating cash flow of $-75.42 Million is below net income of $117.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Atea Pharmaceuticals Inc for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Atea Pharmaceuticals Inc Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Atea Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Atea Pharmaceuticals Inc (AVIR) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Atea Pharmaceuticals Inc (2021–2021)
Year-by-year earnings quality comparison for Atea Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is Atea Pharmaceuticals Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -0.72x | $-87.00 Million | $121.19 Million | — |